Patent assignee · US · COMPANY

OSI Pharmaceuticals, LLC

119Patents
61Active
119Granted
56Portfolio score

Filing activity: Nov 23, 1993 → Jan 10, 2022 · 45 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US6165712A Methods of transcriptionally modulating expression of viral genes and genes useful for production of proteins Emerging Cross-Sectional Technologies 115 Expired
US7534797B2 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors Chemistry; Metallurgy 91 Active
US6680324B2 Compounds specific to adenosine A1 receptors and uses thereof Human Necessities 43 Expired
US6680322B2 Compounds specific to adenosine A1 receptors and uses thereof Human Necessities 40 Expired
US6900221B1 Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof Chemistry; Metallurgy 40 Expired
US7700594B2 Fused bicyclic mTOR inhibitors Chemistry; Metallurgy 34 Active
US7485658B2 N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors Chemistry; Metallurgy 31 Expired
US6136779A Methods of specifically transcriptionally modulating the expression of gene of interest Emerging Cross-Sectional Technologies 29 Expired
US7465726B2 Substituted pyrrolo[2.3-B]pyridines Chemistry; Metallurgy 27 Expired
US6916804B2 Pyrimidine A2b selective antagonist compounds, their synthesis and use Chemistry; Metallurgy 25 Expired
US7459554B2 Imidazopyrazine tyrosine kinase inhibitors Human Necessities 22 Expired
US7504407B2 Compounds specific to adenosine A1 and A3 receptors and uses thereof Human Necessities 22 Expired
US7651687B2 Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Human Necessities 22 Active
US7087613B2 Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride Human Necessities 20 Expired
US6800633B2 Pyrrolo[2,3d]pyrimidine compositions and their use Human Necessities 19 Expired
US8399433B2 Amino pyrimidine anticancer compounds Chemistry; Metallurgy 17 Active
US6686366B1 Compounds specific to adenosine A3 receptor and uses thereof Human Necessities 15 Expired
US7332493B2 Substituted bicyclic derivatives for the treatment of abnormal cell growth Chemistry; Metallurgy 15 Active
US7648987B2 Bicyclic protein kinase inhibitors Human Necessities 14 Active
US6083709A Immunoassay for detection of mutant P53 polypeptide in serum Physics 14 Expired
US6203976A Methods of preparing compositions comprising chemicals capable of transcriptional modulation Emerging Cross-Sectional Technologies 14 Expired
US7790902B2 Isothiazole derivatives useful as anticancer agents Chemistry; Metallurgy 13 Active
US6673802B2 Compounds specific to adenosine A3 receptor and uses thereof Human Necessities 13 Expired
US7923555B2 Fused bicyclic mTor inhibitors Chemistry; Metallurgy 13 Active
US8314111B2 Fused bicyclic motor inhibitors Chemistry; Metallurgy 12 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.